What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysis

Journal of the American College of Cardiology

Volumn 45, Issue 6, 2005, Pages 941-946

  Bavry, Anthony A ^a   Kumbhani, Dharam J ^b   Helton, Thomas J ^a   Bhatt, Deepak L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; METAL; PACLITAXEL; PYRIDINE DERIVATIVE;

ADULT; AGED; CHI SQUARE TEST; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG MEGADOSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; THROMBOSIS;

EID: 14844323640     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.064     Document Type: Article

References (23)

1. J.E. Sousa, M.A. Costa, A. Abizaid Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 103 2001 192 195
2. B.J. Rensing, J. Vos, P.C. Smits Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intra-vascular ultrasonic follow-up Eur Heart J 22 2001 2125 2130
3. R.A. Hill, Y. Dundar, A. Bakhai, R. Dickson, T. Walley Drug-eluting stents: an early systematic review to inform policy Eur Heart J 25 2004 902 919
4. FDA public health notification: updated information for physicians on sub-acute thromboses (SAT) and hypersensitivity reactions with use of the Cordis Cypher sirolimus-eluting coronary stent. Issued November 25, 2003 http://www.fda.gov/cdrh/safety/cypher2.html Accessed January 27, 2005
5. E. Grube, S. Silber, K.E. Hauptmann TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
6. A. Colombo, J. Drzewiecki, A. Banning Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
7. G.W. Stone, S.G. Ellis, D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
8. G.W. Stone, S.G. Ellis, D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent The TAXUS-IV trial Circulation 109 2004 1942 1947
9. K. Dawkins TAXUS VI-30-day results: a randomized double-blind study to assess paclitaxel-eluting stents in the treatment of longer lesions http://www.tctmd.com/display/expert/pdf/71162/Dawkins-TAXUSVI.pdf Accessed January 27, 2005
10. S. Wood Moderate-release paclitaxel-eluting stent outshines bare metal in TAXUS VI http://www.theheart.org/viewArticle.do?primaryKey=568470 Accessed January 27, 2005
11. S.J. Park, W.H. Shim, D.S. Ho A paclitaxel-eluting stent for the prevention of coronary restenosis N Engl J Med 348 2003 1537 1545
12. A. Gershlick, I. De Scheerder, B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493
13. W.D. Knopf DELIVER I--a U.S. multicenter, randomized, single-blind study of the ACHIEVE drug coated coronary stents system: final results and afterthoughts http://www.tctmd.com/display/expert/pdf/79872/knopf- deliverdesstct03.pdf Accessed January 27, 2005
14. A.J. Lansky, R.A. Costa, G.S. Mintz Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions Angiographic follow-up of the DELIVER clinical trial Circulation 109 2004 1948 1954
15. Logic PTX drug-eluting stent--PATENCY: a roll-in feasibility study http://www.tctmd.com/display/expert/pdf/47017/Heldman-PATENCY.pdf Accessed January 27, 2005
16. A.W. Heldman, N. Farhat, E. Fry Paclitaxel-eluting stent for cytostatic prevention of restenosis: PATENCY study follow-up Am J Cardiol 90 Suppl 1 2002 3H
17. D.L. Bhatt, M.E. Bertrand, P.B. Berger Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting J Am Coll Cardiol 39 2002 9 14
18. E. Grube, K. Hauptmann, A. Colombo SCORE trial interim safety results: despite efficacy, late stent thrombosis with the QuaDDS-QP2 stent (abstr) J Am Coll Cardiol 39 Suppl A 2002 38A
19. A. Cheiffo, E. Bonizzoni, D. Orlic Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents Circulation 109 2004 2732 2736
20. E. Cheneau, L. Leborgne, G.S. Mintz Predictors of subacute stent thrombosis Results of a systematic intravascular ultrasound study Circulation 108 2003 43 47
21. D.E. Cutlip, D.S. Baim, K.K.L. Ho Stent thrombosis in the modern era A pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
22. I. Moussa, C. Di Mario, B. Reimers Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcomes J Am Coll Cardiol 29 1997 6 12
23. M.N. Babapulle, L. Joseph, P. Belisle, J.M. Brophy, M.J. Eisenberg A hierarchiacal Bayesian meta-analysis of randomized clinical trials of drug-eluting stents Lancet 364 2004 583 591